Articles Archives
Articles
07/20/2026
Expert Q&A: Going Deeper on Early Supply Chain Strategy for CGT Programs
Advanced therapy developers rarely have the luxury of perfect timing. Programs are often moving toward the next milestone with limited resources, data that’s evolving in real time, and pressure to make decisions before every variable is fully understood. That reality was at the center of the recent webinar, “Prevent Advanced Therapy Program Delays with Early Supply Chain Strategy,” where panelists discussed how early decisions around logistics, cryopreservation, packaging, site readiness, documentation, and cross-functional alignment can influence everything downstream.
Articles
10/30/2025
Cryoport Systems Sets New Benchmark for the Global Regenerative Medicine Supply Chain
Cryoport Systems has achieved a significant milestone by becoming the first global supply chain company worldwide to secure ISO 21973:2020 certification from the DNV Business Assurance. This certification marks a pivotal advancement in our mission to set the highest benchmarks for safety, traceability, and product integrity in the cell and gene therapy sector and across the life sciences.
Articles
05/19/2025
Addressing the EMEA Cold Chain Challenge for Cell and Gene Therapies: Cryoport Systems Featured in Labiotech.eu
In a recent Labiotech.eu article, Florent Belon, Managing Director for Cryoport Systems in France, discusses how regulatory diversity, infrastructure gaps, and extreme climate variation across EMEA intensify the need for customized, compliant cold chain solutions.
Articles
04/22/2025
